Le Lézard
Classified in: Health
Subjects: PDT, TRI

BREVENA Laboratories' Restorative Skin Balm Helps To Soothe Eczema Flare-Ups


SAINT PAUL, Minn., July 13, 2018 /PRNewswire/ -- BREVENA Laboratories, LLC, a luxury skin care cosmetics company, announces that their Restorative Skin Balm provides soothing relief for Eczema prone skin. Eczema is a condition that causes the skin to become dry, itchy, and irritated. Eczema causes damage to the skin's barrier, making it difficult to retain water, so adding moisture to the skin is vital. In clinical trials of BREVENA's Restorative Skin Balm, 100% of consumers showed an improvement in the skin's texture and hydration in just one use, and showed additional improvement with continued use.

(PRNewsfoto/BREVENA)

Macro B Complex®, BREVENA Laboratories' exclusive ingredient, is botanically derived from the cell wall of oats.  Oats have been used historically in oatmeal baths to help soothe the skin after exposure to aggressive environmental factors. The oat derivative then undergoes a proprietary process to improve its efficacy resulting in the groundbreaking formula that transforms damaged skin.  This technology has been used and trusted by medical professionals over the past twenty years to heal traumatic wounds, and is now available in the luxury skin care market only in BREVENA products.

About BREVENA Laboratories, LLC: BREVENA Laboratories is a luxury skin care company that utilizes three decades of experience in wound care to develop advanced clinical grade skin care products. BREVENA's mission is to be most trusted brand for essential skin health.  SKIN MATTERS. LOVE YOUR SKIN®

Please contact Julia McMann if you would like product samples for a feature. 651-407-8131, [email protected]

 

SOURCE BREVENA Laboratories, LLC


These press releases may also interest you

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...

at 06:00
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to ?275 Million, Consisting of ?190 Million in Cash Upfront and up to ?85 Million in...

at 06:00
Dr. Luz Hernandez, a leading dentist in Tampa, Florida has redefined her practice to focus on facial aesthetics. Facial Aesthetics by Dr. Luz, https://www.drluzh.com/, provides a wide...

at 06:00
West Pharmaceutical Services, Inc. today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance....

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...



News published on and distributed by: